{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:57:00Z","timestamp":1793429820598,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["Investigator Award"],"award-info":[{"award-number":["Investigator Award"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM122455"],"award-info":[{"award-number":["R35GM122455"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015138","name":"Marriott Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015138","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41587-019-0377-7","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T12:02:48Z","timestamp":1578916968000},"page":"309-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD+ imbalance"],"prefix":"10.1038","volume":"38","author":[{"given":"Anupam","family":"Patgiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen S.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorij","family":"Schleifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizo","family":"Marutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-5686","authenticated-orcid":false,"given":"Hardik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz-Leung","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-2944","authenticated-orcid":false,"given":"Xiaoyan","family":"Robert Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren M.","family":"Zapol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-642X","authenticated-orcid":false,"given":"Vamsi K.","family":"Mootha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"377_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nature11707","volume":"491","author":"SB Vafai","year":"2012","unstructured":"Vafai, S. B. & Mootha, V. K. Mitochondrial disorders as windows into an ancient organelle. Nature 491, 374\u2013383 (2012).","journal-title":"Nature"},{"key":"377_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.celrep.2015.09.054","volume":"13","author":"J Thompson Legault","year":"2015","unstructured":"Thompson Legault, J. et al. A metabolic signature of mitochondrial dysfunction revealed through a monogenic form of Leigh syndrome. Cell Rep. 13, 981\u2013989 (2015).","journal-title":"Cell Rep."},{"key":"377_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.aad4017","volume":"352","author":"DV Titov","year":"2016","unstructured":"Titov, D. V. et al. Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio. Science 352, 231\u2013235 (2016).","journal-title":"Science"},{"key":"377_CR4","doi-asserted-by":"publisher","unstructured":"Xiao, W. & Loscalzo, J. Metabolic responses to reductive stress. Antioxid. Redox Signal https:\/\/doi.org\/10.1089\/ars.2019.7803 (2019).","DOI":"10.1089\/ars.2019.7803"},{"key":"377_CR5","doi-asserted-by":"publisher","first-page":"C347","DOI":"10.1152\/ajpcell.1989.257.2.C347","volume":"257","author":"GJ Gores","year":"1989","unstructured":"Gores, G. J. et al. Swelling, reductive stress, and cell death during chemical hypoxia in hepatocytes. Am. J. Physiol. 257, C347\u2013C354 (1989).","journal-title":"Am. J. Physiol."},{"key":"377_CR6","first-page":"146","volume":"118","author":"WM Tilton","year":"1991","unstructured":"Tilton, W. M., Seaman, C., Carriero, D. & Piomelli, S. Regulation of glycolysis in the erythrocyte: role of the lactate\/pyruvate and NAD\/NADH ratios. J. Lab. Clin. Med. 118, 146\u2013152 (1991).","journal-title":"J. Lab. Clin. Med."},{"key":"377_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/diab.42.6.801","volume":"42","author":"JR Williamson","year":"1993","unstructured":"Williamson, J. R. et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801\u2013813 (1993).","journal-title":"Diabetes"},{"key":"377_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1042\/bj1030514","volume":"103","author":"DH Williamson","year":"1967","unstructured":"Williamson, D. H., Lund, P. & Krebs, H. A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103, 514\u2013527 (1967).","journal-title":"Biochem. J."},{"key":"377_CR9","doi-asserted-by":"publisher","first-page":"C761","DOI":"10.1152\/ajpcell.1993.264.4.C761","volume":"264","author":"RC Poole","year":"1993","unstructured":"Poole, R. C. & Halestrap, A. P. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264, C761\u2013C782 (1993).","journal-title":"Am. J. Physiol."},{"key":"377_CR10","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1073\/pnas.0906039107","volume":"107","author":"O Shaham","year":"2010","unstructured":"Shaham, O. et al. A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc. Natl Acad. Sci. USA 107, 1571\u20131575 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"377_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1432-1033.1972.tb01840.x","volume":"27","author":"T Bucher","year":"1972","unstructured":"Bucher, T. et al. State of oxidation-reduction and state of binding in the cytosolic NADH-system as disclosed by equilibration with extracellular lactate-pyruvate in hemoglobin-free perfused rat liver. Eur. J. Biochem. 27, 301\u2013317 (1972).","journal-title":"Eur. J. Biochem."},{"key":"377_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cmet.2011.08.012","volume":"14","author":"YP Hung","year":"2011","unstructured":"Hung, Y. P., Albeck, J. G., Tantama, M. & Yellen, G. Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab. 14, 545\u2013554 (2011).","journal-title":"Cell Metab."},{"key":"377_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ymgme.2014.04.008","volume":"112","author":"T Fujii","year":"2014","unstructured":"Fujii, T. et al. Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study. Mol. Genet. Metab. 112, 133\u2013138 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"377_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bbagen.2011.08.006","volume":"1820","author":"K Saito","year":"2012","unstructured":"Saito, K. et al. Pyruvate therapy for mitochondrial DNA depletion syndrome. Biochim. Biophys. Acta 1820, 632\u2013636 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"377_CR15","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.bbrc.2007.05.021","volume":"358","author":"SJ Li","year":"2007","unstructured":"Li, S. J. et al. Crystallographic study on the interaction of l-lactate oxidase with pyruvate at 1.9 Angstrom resolution. Biochem. Biophys. Res. Comm. 358, 1002\u20131007 (2007).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"377_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/prot.1092","volume":"44","author":"W Melik-Adamyan","year":"2001","unstructured":"Melik-Adamyan, W. et al. Substrate flow in catalases deduced from the crystal structures of active site variants of HPII from Escherichia coli. Proteins 44, 270\u2013281 (2001).","journal-title":"Proteins"},{"key":"377_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.electacta.2013.01.080","volume":"93","author":"IRR Taurino","year":"2013","unstructured":"Taurino, I. R. R. et al. Comparative study of three lactate oxidases from Aerococcus viridans for biosensing applications. Electrochim. Acta 93, 72\u201379 (2013).","journal-title":"Electrochim. Acta"},{"key":"377_CR18","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1073\/pnas.1218769110","volume":"110","author":"C Andre","year":"2013","unstructured":"Andre, C., Kim, S. W., Yu, X. H. & Shanklin, J. Fusing catalase to an alkane-producing enzyme maintains enzymatic activity by converting the inhibitory byproduct H2O2 to the cosubstrate O2. Proc. Natl Acad. Sci. USA 110, 3191\u20133196 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"377_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/nature04031","volume":"437","author":"A Martin","year":"2005","unstructured":"Martin, A., Baker, T. A. & Sauer, R. T. Rebuilt AAA+ motors reveal operating principles for ATP-fuelled machines. Nature 437, 1115\u20131120 (2005).","journal-title":"Nature"},{"key":"377_CR20","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/S0021-9258(18)95956-9","volume":"242","author":"DE Atkinson","year":"1967","unstructured":"Atkinson, D. E. & Walton, G. M. Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. J. Biol. Chem. 242, 3239\u20133241 (1967).","journal-title":"J. Biol. Chem."},{"key":"377_CR21","doi-asserted-by":"publisher","first-page":"e108676","DOI":"10.1371\/journal.pone.0108676","volume":"9","author":"IM De la Fuente","year":"2014","unstructured":"De la Fuente, I. M. et al. On the dynamics of the adenylate energy system: homeorhesis vs homeostasis. PLoS ONE 9, e108676 (2014).","journal-title":"PLoS ONE"},{"key":"377_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1126\/science.2814477","volume":"246","author":"MP King","year":"1989","unstructured":"King, M. P. & Attardi, G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500\u2013503 (1989).","journal-title":"Science"},{"key":"377_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/cge.13089","volume":"93","author":"F Baertling","year":"2018","unstructured":"Baertling, F. et al. NDUFA9 point mutations cause a variable mitochondrial complex I assembly defect. Clin. Genet. 93, 111\u2013118 (2018).","journal-title":"Clin. Genet."},{"key":"377_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00439-003-0946-0","volume":"113","author":"S Haut","year":"2003","unstructured":"Haut, S. et al. A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum. Genet. 113, 118\u2013122 (2003).","journal-title":"Hum. Genet."},{"key":"377_CR25","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/brain\/awt086","volume":"136","author":"AI Jonckheere","year":"2013","unstructured":"Jonckheere, A. I. et al. A complex V ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy. Brain 136, 1544\u20131554 (2013).","journal-title":"Brain"},{"key":"377_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.kint.2018.08.038","volume":"95","author":"SC Johnson","year":"2019","unstructured":"Johnson, S. C. et al. mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases. Kidney Int. 95, 455\u2013466 (2019).","journal-title":"Kidney Int."},{"key":"377_CR27","doi-asserted-by":"publisher","first-page":"e106422","DOI":"10.1371\/journal.pone.0106422","volume":"9","author":"J Mukherjee","year":"2014","unstructured":"Mukherjee, J. et al. Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein. PLoS ONE 9, e106422 (2014).","journal-title":"PLoS ONE"},{"key":"377_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/protein\/gzl011","volume":"19","author":"A Nguyen","year":"2006","unstructured":"Nguyen, A. et al. The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin. Protein Eng. Des. Sel. 19, 291\u2013297 (2006).","journal-title":"Protein Eng. Des. Sel."},{"key":"377_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cmet.2016.09.006","volume":"24","author":"DY Gui","year":"2016","unstructured":"Gui, D. Y. et al. Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin. Cell Metab. 24, 716\u2013727 (2016).","journal-title":"Cell Metab."},{"key":"377_CR30","doi-asserted-by":"publisher","first-page":"e0122818","DOI":"10.1371\/journal.pone.0122818","volume":"10","author":"L Nocito","year":"2015","unstructured":"Nocito, L. et al. The extracellular redox state modulates mitochondrial function, gluconeogenesis, and glycogen synthesis in murine hepatocytes. PLoS ONE 10, e0122818 (2015).","journal-title":"PLoS ONE"},{"key":"377_CR31","doi-asserted-by":"publisher","first-page":"L972","DOI":"10.1152\/ajplung.00010.2007","volume":"293","author":"A Ramirez","year":"2007","unstructured":"Ramirez, A. et al. Extracellular cysteine\/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-\u03b2. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L972\u2013L981 (2007).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"377_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","volume":"28","author":"HJ Muller","year":"1998","unstructured":"Muller, H. J. & Boos, J. Use of l-asparaginase in childhood ALL. Crit. Rev. Oncol. Hematol. 28, 97\u2013113 (1998).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"377_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1056\/NEJM198409203111205","volume":"311","author":"GL Laffel","year":"1984","unstructured":"Laffel, G. L. & Braunwald, E. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (2). N. Engl. J. Med. 311, 770\u2013776 (1984).","journal-title":"N. Engl. J. Med."},{"key":"377_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cmet.2016.08.017","volume":"24","author":"JD Arroyo","year":"2016","unstructured":"Arroyo, J. D. et al. A genome-wide CRISPR death screen identifies genes essential for oxidative phosphorylation. Cell Metab. 24, 875\u2013885 (2016).","journal-title":"Cell Metab."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41587-019-0377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41587-019-0377-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41587-019-0377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:14:19Z","timestamp":1684606459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-019-0377-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1038\/s41587-019-0377-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737201527.793569961","asserted-by":"object"}]},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"5 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Massachusetts General Hospital has filed a patent on the technology described in this paper listing V.K.M., A.P. and X.R.B as inventors. O.S.S. is a paid consultant for Proteinaceous Inc. V.K.M. is a paid advisor to Janssen Pharmaceuticals and 5AM Ventures and is a founder of Raze Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}